BIOMAT Database Logo BIOMAT Database Logo

[Hypoaldosteronism induced by low molecular weight heparins]. 1991

H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois

UI MeSH Term Description Entries
D006994 Hypoaldosteronism A congenital or acquired condition of insufficient production of ALDOSTERONE by the ADRENAL CORTEX leading to diminished aldosterone-mediated synthesis of Na(+)-K(+)-EXCHANGING ATPASE in renal tubular cells. Clinical symptoms include HYPERKALEMIA, sodium-wasting, HYPOTENSION, and sometimes metabolic ACIDOSIS. Acidosis, Renal Tubular Type IV,Hypoaldosteronism, Hyporeninemic,Renal Tubular Acidosis, Type IV,Type IV Renal Tubular Acidosis,Hyporeninemic Hypoaldosteronism
D008297 Male Males
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D005260 Female Females
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer

Related Publications

H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
Bullous hemorrhagic dermatosis induced by low molecular weight heparins.
August 2020, Medicina clinica,
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
Low molecular weight heparins.
September 1994, Current opinion in cardiology,
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
[Low molecular weight heparins].
January 1990, Medicina (Florence, Italy),
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
Low-molecular-weight heparins.
September 1997, The New England journal of medicine,
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
Low-molecular-weight heparins.
December 1998, Hematology/oncology clinics of North America,
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
[Low molecular weight heparins].
December 1993, Presse medicale (Paris, France : 1983),
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
[Low molecular weight heparins].
January 1986, Pathologie-biologie,
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
[Low-molecular-weight heparins].
April 1993, Medicina clinica,
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
[Low-molecular-weight heparins].
April 1998, Der Internist,
H Levesque, and N Cailleux, and C Noblet, and A Gancel, and N Moore, and H Courtois
[Low molecular weight heparins].
January 1989, Annales pharmaceutiques francaises,
Copied contents to your clipboard!